RETRACTED: HNF-4α inhibits hepatocellular carcinoma cell proliferation through mir-122-adam17 pathway (Retracted Article)

被引:21
|
作者
Yang, Guang [1 ]
Zhang, Min [2 ]
Zhao, Yawei [2 ]
Pan, Yue [2 ]
Kan, Mujie [3 ]
Li, Jing [2 ]
He, Kan [2 ]
Zhang, Xuewen [1 ]
机构
[1] Jilin Univ, Affiliated Hosp 2, Dept Hepatobiliary & Pancreat Surg, Changchun, Jilin, Peoples R China
[2] Jilin Univ, Coll Basic Med Sci, Dept Pharmacol, Changchun, Peoples R China
[3] Jilin Univ, Dept Biochem, Coll Basic Med Sci, Changchun, Peoples R China
来源
PLOS ONE | 2020年 / 15卷 / 03期
关键词
EXPRESSION; MICRORNA-122;
D O I
10.1371/journal.pone.0230450
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Hepatocellular carcinoma (HCC) is one of the most common human cancers, its prevalence and severity need us to discover novel early diagnostic biomarkers and new therapeutic strategies. MicroRNA-122 is the most abundant microRNA in the liver, and acts as a tumor suppressor and represses HCC development. In our study we showed that HNF-4 alpha and MiR-122 were down-regulated significantly in hepatocellular carcinoma. Over-expression of HNF-4 alpha inhibit hepatocellular carcinoma cells proliferation. And miR-122 is one of the down-stream effector of HNF-4 alpha. Up-regulated miR-122 inhibited hepatocellular carcinoma cells proliferation through regulating ADAM17. Collectively, our results suggested that HNF-4 alpha could inhibit hepatocellular carcinoma proliferation with miR-122 being a downstream target of it. And miR-122 would inhibit hepatocellular carcinoma proliferation by regulating ADAM17 signal pathway.
引用
收藏
页数:10
相关论文
共 50 条
  • [31] RETRACTED: Quercetin Inhibits KBM7R Cell Proliferation through Wnt/β-Catenin Signaling (Retracted Article)
    Li, Wei
    Yu, Yang
    Cheng, Huanchen
    Liu, Shengwei
    Gong, Tiejun
    Ma, Jun
    Tang, Qinghua
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2022, 2022
  • [32] RETRACTED: miR-30a-5p Inhibits Proliferation and Migration of Lung Squamous Cell Carcinoma Cells by Targeting FOXD1 (Retracted Article)
    Chen, Chunhua
    Tang, Junhua
    Xu, Shan
    Zhang, Wenxia
    Jiang, Hanliang
    BIOMED RESEARCH INTERNATIONAL, 2020, 2020
  • [33] RETRACTED: miR-488 inhibits cell growth and metastasis in renal cell carcinoma by targeting HMGN5 (Retracted Article)
    Wei, Xin
    Yu, Lili
    Kong, Xiangbo
    ONCOTARGETS AND THERAPY, 2018, 11 : 2205 - 2216
  • [34] RETRACTED: LncRNA GAS5 inhibits proliferation and progression of prostate cancer by targeting miR-103 through AKT/mTOR signaling pathway (Retracted Article)
    Xue, Dong
    Zhou, Cuixing
    Lu, Hao
    Xu, Renfang
    Xu, Xianlin
    He, Xiaozhou
    TUMOR BIOLOGY, 2016, 37 (12) : 16187 - 16197
  • [35] RETRACTED: MiR-195-5p inhibits the cell migration and invasion of cervical carcinoma through suppressing ARL2 (Retracted Article)
    Pan, S-S
    Zhou, H-E
    Yu, H-Y
    Xu, L-H
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2019, 23 (24) : 10664 - 10671
  • [36] RETRACTED: Betulin inhibits lung carcinoma proliferation through activation of AMPK signaling (Retracted article. See April, 2017)
    Li, Xian-Dong
    Zhang, Yi-Jie
    Han, Ji-Chang
    TUMOR BIOLOGY, 2014, 35 (11) : 11153 - 11158
  • [37] RETRACTED: MicroRNA-573 inhibits cell proliferation, migration, and invasion and is downregulated by PICSAR in cutaneous squamous cell carcinoma (Retracted Article)
    Wang, Yanhua
    Tang, Shengjian
    Lv, Jianping
    BOSNIAN JOURNAL OF BASIC MEDICAL SCIENCES, 2022, 22 (02) : 229 - 237
  • [38] RETRACTED: Alkannin inhibits proliferation, migration and invasion of hepatocellular carcinoma cells via regulation of miR-92a (Retracted article. See vol. 146, 2022)
    Sun, Baozhen
    Zhang, Jingzhe
    Liu, Meihan
    Guan, Lianyue
    BIOMEDICINE & PHARMACOTHERAPY, 2019, 114
  • [39] RETRACTED: miR-365 targets ADAM10 and suppresses the cell growth and metastasis of hepatocellular carcinoma (Retracted article. See vol. 48, 2022)
    Liu, Yahui
    Zhang, Wei
    Liu, Songyang
    Liu, Kai
    Ji, Bai
    Wang, Yingchao
    ONCOLOGY REPORTS, 2017, 37 (03) : 1857 - 1864
  • [40] RETRACTED: miR-132 inhibits cell proliferation, invasion and migration of hepatocellular carcinoma by targeting PIK3R3 (Retracted article. See vol. 59, 2021)
    Liu, Kai
    Li, Xingliang
    Cao, Yuchen
    Ge, Yuanyuan
    Wang, Jianmeng
    Shi, Bo
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2015, 47 (04) : 1585 - 1593